Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Molecular Diagnostic Techniques | 3 | 2020 | 626 | 0.970 |
Why?
|
Pathology, Molecular | 4 | 2017 | 347 | 0.850 |
Why?
|
Laboratories, Hospital | 2 | 2020 | 199 | 0.750 |
Why?
|
Colonic Neoplasms | 17 | 2020 | 2535 | 0.740 |
Why?
|
Clinical Laboratory Techniques | 2 | 2020 | 743 | 0.560 |
Why?
|
Pancreatic Cyst | 1 | 2017 | 346 | 0.510 |
Why?
|
Telomere | 1 | 2017 | 823 | 0.450 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2013 | 427 | 0.430 |
Why?
|
Genetic Diseases, Inborn | 1 | 2016 | 598 | 0.420 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1630 | 0.380 |
Why?
|
Colitis | 4 | 2020 | 1140 | 0.290 |
Why?
|
Gene Expression Regulation, Neoplastic | 12 | 2020 | 8638 | 0.250 |
Why?
|
Pancreatic Neoplasms | 2 | 2017 | 4930 | 0.230 |
Why?
|
Azoxymethane | 7 | 2011 | 35 | 0.220 |
Why?
|
Ursodeoxycholic Acid | 3 | 2008 | 63 | 0.210 |
Why?
|
Transcription, Genetic | 2 | 2013 | 7965 | 0.200 |
Why?
|
Precancerous Conditions | 4 | 2012 | 964 | 0.200 |
Why?
|
Genetic Variation | 1 | 2016 | 6666 | 0.200 |
Why?
|
Cyclooxygenase 2 | 5 | 2009 | 624 | 0.190 |
Why?
|
Cord Blood Stem Cell Transplantation | 2 | 2013 | 338 | 0.190 |
Why?
|
MicroRNAs | 4 | 2020 | 3655 | 0.180 |
Why?
|
Utilization Review | 1 | 2020 | 400 | 0.180 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2019 | 176 | 0.170 |
Why?
|
Neoplasms | 3 | 2016 | 20172 | 0.170 |
Why?
|
Cost Control | 1 | 2020 | 628 | 0.170 |
Why?
|
Losartan | 1 | 2019 | 254 | 0.160 |
Why?
|
Genes, ras | 4 | 2013 | 719 | 0.160 |
Why?
|
Chemokine CXCL2 | 1 | 2016 | 120 | 0.150 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2020 | 411 | 0.150 |
Why?
|
Receptors, Calcitriol | 2 | 2019 | 345 | 0.150 |
Why?
|
ras Proteins | 4 | 2014 | 1116 | 0.140 |
Why?
|
Transplantation Conditioning | 3 | 2013 | 1553 | 0.140 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2017 | 908 | 0.140 |
Why?
|
Proto-Oncogene Proteins | 5 | 2014 | 4677 | 0.140 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2014 | 68 | 0.130 |
Why?
|
Transforming Growth Factor alpha | 2 | 2016 | 139 | 0.130 |
Why?
|
Receptor Cross-Talk | 1 | 2014 | 124 | 0.130 |
Why?
|
RNA | 1 | 2004 | 2680 | 0.130 |
Why?
|
Sarcoma, Myeloid | 1 | 2014 | 56 | 0.130 |
Why?
|
Oncogene Proteins v-myb | 1 | 2013 | 27 | 0.130 |
Why?
|
DNA Mutational Analysis | 4 | 2016 | 4317 | 0.120 |
Why?
|
Cytogenetic Analysis | 1 | 2014 | 306 | 0.120 |
Why?
|
Indazoles | 1 | 2015 | 292 | 0.120 |
Why?
|
Asymptomatic Diseases | 1 | 2016 | 577 | 0.120 |
Why?
|
Paraffin Embedding | 1 | 2014 | 317 | 0.120 |
Why?
|
Telomerase | 1 | 2017 | 741 | 0.120 |
Why?
|
Dextran Sulfate | 2 | 2011 | 251 | 0.120 |
Why?
|
Colon | 4 | 2014 | 1762 | 0.120 |
Why?
|
Microsatellite Instability | 1 | 2016 | 664 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-pim-1 | 1 | 2012 | 34 | 0.120 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2014 | 581 | 0.110 |
Why?
|
Colitis, Ulcerative | 3 | 2013 | 1825 | 0.110 |
Why?
|
Receptors, CXCR4 | 1 | 2016 | 724 | 0.110 |
Why?
|
Iodine Radioisotopes | 1 | 2015 | 1034 | 0.100 |
Why?
|
Paxillin | 1 | 2010 | 93 | 0.100 |
Why?
|
Lymphoma, T-Cell | 1 | 2013 | 296 | 0.100 |
Why?
|
Microarray Analysis | 1 | 2014 | 777 | 0.100 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 2 | 2008 | 102 | 0.100 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2010 | 92 | 0.100 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2013 | 603 | 0.100 |
Why?
|
PTEN Phosphohydrolase | 1 | 2017 | 1158 | 0.100 |
Why?
|
DNA Copy Number Variations | 2 | 2016 | 1894 | 0.100 |
Why?
|
Proto-Oncogenes | 1 | 2011 | 328 | 0.100 |
Why?
|
Cholecalciferol | 2 | 2007 | 482 | 0.100 |
Why?
|
Incidental Findings | 1 | 2015 | 668 | 0.100 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2011 | 277 | 0.100 |
Why?
|
Renin-Angiotensin System | 1 | 2014 | 754 | 0.090 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2014 | 1126 | 0.090 |
Why?
|
Carcinoma, Papillary | 1 | 2015 | 798 | 0.090 |
Why?
|
Gene Expression Profiling | 2 | 2013 | 9556 | 0.090 |
Why?
|
Education, Medical, Undergraduate | 1 | 2018 | 988 | 0.090 |
Why?
|
Haplotypes | 2 | 2013 | 2874 | 0.090 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2013 | 679 | 0.090 |
Why?
|
Insurance Coverage | 1 | 2020 | 1847 | 0.090 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 5 | 2014 | 1667 | 0.090 |
Why?
|
Antibodies, Neoplasm | 1 | 2009 | 311 | 0.080 |
Why?
|
Benzimidazoles | 1 | 2013 | 882 | 0.080 |
Why?
|
Imidazoles | 1 | 2015 | 1268 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2017 | 2971 | 0.080 |
Why?
|
Adenoma | 2 | 2010 | 2130 | 0.080 |
Why?
|
Humans | 34 | 2020 | 708843 | 0.080 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2014 | 3006 | 0.080 |
Why?
|
Chromosome Aberrations | 1 | 2014 | 1814 | 0.080 |
Why?
|
Pancreatitis | 1 | 2013 | 1048 | 0.080 |
Why?
|
Reproducibility of Results | 2 | 2016 | 19423 | 0.080 |
Why?
|
Transplantation Chimera | 1 | 2009 | 623 | 0.080 |
Why?
|
Down-Regulation | 4 | 2020 | 3093 | 0.080 |
Why?
|
Lymphoma, B-Cell | 1 | 2013 | 917 | 0.080 |
Why?
|
Stromal Cells | 1 | 2012 | 1361 | 0.080 |
Why?
|
Curriculum | 2 | 2018 | 3329 | 0.080 |
Why?
|
Mutation | 7 | 2017 | 29262 | 0.080 |
Why?
|
Prognosis | 3 | 2016 | 28919 | 0.080 |
Why?
|
Genes, Tumor Suppressor | 1 | 2011 | 1095 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2016 | 3708 | 0.070 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2008 | 421 | 0.070 |
Why?
|
Lymphoma | 2 | 2012 | 1871 | 0.070 |
Why?
|
Adenoma, Villous | 1 | 2005 | 14 | 0.070 |
Why?
|
Genetic Heterogeneity | 1 | 2009 | 749 | 0.070 |
Why?
|
Disease Models, Animal | 5 | 2019 | 18375 | 0.070 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2011 | 758 | 0.070 |
Why?
|
Vitamin D | 1 | 2019 | 3138 | 0.070 |
Why?
|
Colonic Polyps | 1 | 2010 | 531 | 0.070 |
Why?
|
Genomics | 2 | 2018 | 5300 | 0.070 |
Why?
|
Cyclin D1 | 2 | 2007 | 470 | 0.070 |
Why?
|
DNA-Binding Proteins | 2 | 2013 | 9774 | 0.070 |
Why?
|
Medical Oncology | 1 | 2016 | 2098 | 0.070 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 737 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 2015 | 2708 | 0.060 |
Why?
|
HIV | 1 | 2011 | 1489 | 0.060 |
Why?
|
Graft Survival | 2 | 2013 | 3767 | 0.060 |
Why?
|
Hepacivirus | 1 | 2011 | 1309 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8896 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4941 | 0.060 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5235 | 0.060 |
Why?
|
Up-Regulation | 4 | 2020 | 4353 | 0.060 |
Why?
|
Hematopoiesis | 1 | 2013 | 2015 | 0.060 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2013 | 1481 | 0.060 |
Why?
|
RNA, Viral | 1 | 2011 | 2847 | 0.060 |
Why?
|
Antineoplastic Agents | 3 | 2017 | 13714 | 0.060 |
Why?
|
Viral Load | 1 | 2011 | 3231 | 0.060 |
Why?
|
Microsatellite Repeats | 1 | 2005 | 807 | 0.060 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 350 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 2 | 2013 | 200 | 0.060 |
Why?
|
Graft vs Host Disease | 2 | 2011 | 2818 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 2865 | 0.060 |
Why?
|
Mice | 12 | 2020 | 80876 | 0.060 |
Why?
|
Autoimmune Diseases | 1 | 2013 | 2117 | 0.050 |
Why?
|
Repressor Proteins | 1 | 2013 | 3075 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2015 | 2219 | 0.050 |
Why?
|
Reference Standards | 1 | 2004 | 992 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 2 | 2017 | 5405 | 0.050 |
Why?
|
HCT116 Cells | 2 | 2012 | 412 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2013 | 4065 | 0.050 |
Why?
|
Karyopherins | 1 | 2020 | 138 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 8024 | 0.050 |
Why?
|
Lung Neoplasms | 2 | 2017 | 12183 | 0.050 |
Why?
|
Retroviridae | 2 | 2013 | 957 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2013 | 14836 | 0.050 |
Why?
|
Animals | 16 | 2020 | 170486 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5982 | 0.050 |
Why?
|
Immunohistochemistry | 5 | 2013 | 11790 | 0.040 |
Why?
|
Transplantation, Homologous | 3 | 2013 | 4831 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2016 | 4810 | 0.040 |
Why?
|
Transcription Factors | 3 | 2014 | 12005 | 0.040 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2013 | 3281 | 0.040 |
Why?
|
Isoenzymes | 1 | 2003 | 1812 | 0.040 |
Why?
|
Adenocarcinoma | 3 | 2017 | 6338 | 0.040 |
Why?
|
Cadherins | 1 | 2002 | 921 | 0.040 |
Why?
|
Neoplasm Proteins | 1 | 2010 | 3773 | 0.040 |
Why?
|
Mice, Inbred A | 2 | 2007 | 254 | 0.040 |
Why?
|
Polymerase Chain Reaction | 2 | 2004 | 6293 | 0.040 |
Why?
|
Inflammation | 2 | 2020 | 10019 | 0.040 |
Why?
|
RNA, Messenger | 5 | 2013 | 13314 | 0.040 |
Why?
|
Cell Line, Tumor | 4 | 2016 | 16959 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2017 | 61932 | 0.040 |
Why?
|
Spiro Compounds | 1 | 2016 | 87 | 0.040 |
Why?
|
Ligands | 2 | 2016 | 3297 | 0.040 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2019 | 472 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2017 | 2936 | 0.040 |
Why?
|
Antibodies, Monoclonal | 2 | 2011 | 9584 | 0.040 |
Why?
|
Blotting, Western | 3 | 2011 | 5456 | 0.030 |
Why?
|
Government Regulation | 1 | 2020 | 542 | 0.030 |
Why?
|
Cyclooxygenase 2 Inhibitors | 2 | 2008 | 329 | 0.030 |
Why?
|
Models, Educational | 1 | 2018 | 396 | 0.030 |
Why?
|
Mice, Knockout | 3 | 2019 | 15274 | 0.030 |
Why?
|
Problem-Based Learning | 1 | 2018 | 339 | 0.030 |
Why?
|
Rats, Inbred F344 | 2 | 2008 | 876 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-3 | 1 | 2015 | 127 | 0.030 |
Why?
|
Interleukin-1beta | 2 | 2012 | 953 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2020 | 1652 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17218 | 0.030 |
Why?
|
Signal Transduction | 6 | 2016 | 23950 | 0.030 |
Why?
|
Intestinal Mucosa | 3 | 2013 | 3070 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2013 | 6497 | 0.030 |
Why?
|
Diet | 1 | 2011 | 7392 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2014 | 258 | 0.030 |
Why?
|
Smad4 Protein | 1 | 2013 | 169 | 0.030 |
Why?
|
Male | 16 | 2015 | 349524 | 0.030 |
Why?
|
Immunoglobulin Isotypes | 1 | 2013 | 160 | 0.030 |
Why?
|
Formaldehyde | 1 | 2014 | 358 | 0.030 |
Why?
|
Middle Aged | 11 | 2015 | 213752 | 0.030 |
Why?
|
DNA Methylation | 2 | 2020 | 4099 | 0.030 |
Why?
|
Radiation Tolerance | 1 | 2015 | 509 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2015 | 745 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2009 | 5135 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2015 | 559 | 0.030 |
Why?
|
Lymphocyte Subsets | 1 | 2013 | 325 | 0.030 |
Why?
|
Illinois | 1 | 2011 | 113 | 0.030 |
Why?
|
Neoplasms, Experimental | 2 | 2011 | 1338 | 0.030 |
Why?
|
Transfection | 2 | 2012 | 6161 | 0.030 |
Why?
|
Aged | 9 | 2015 | 161488 | 0.030 |
Why?
|
Genetic Counseling | 1 | 2015 | 577 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2015 | 582 | 0.030 |
Why?
|
Pharmacogenetics | 1 | 2016 | 697 | 0.030 |
Why?
|
Angiotensin II | 1 | 2014 | 921 | 0.030 |
Why?
|
Mucin-6 | 1 | 2010 | 17 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2013 | 813 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6571 | 0.030 |
Why?
|
Vitamins | 1 | 2019 | 1466 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2019 | 10803 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2019 | 22989 | 0.020 |
Why?
|
Quinazolines | 2 | 2008 | 1420 | 0.020 |
Why?
|
Adult | 9 | 2015 | 211041 | 0.020 |
Why?
|
Gene Amplification | 1 | 2015 | 1087 | 0.020 |
Why?
|
Genes, erbB-1 | 1 | 2010 | 168 | 0.020 |
Why?
|
GTPase-Activating Proteins | 1 | 2013 | 495 | 0.020 |
Why?
|
Rotation | 1 | 2011 | 519 | 0.020 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2013 | 473 | 0.020 |
Why?
|
G1 Phase | 1 | 2011 | 422 | 0.020 |
Why?
|
Rats | 4 | 2011 | 25094 | 0.020 |
Why?
|
Female | 12 | 2015 | 375205 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2013 | 9927 | 0.020 |
Why?
|
Antigens, CD34 | 1 | 2011 | 673 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2013 | 796 | 0.020 |
Why?
|
Mutagenesis, Insertional | 1 | 2012 | 667 | 0.020 |
Why?
|
Apoptosis | 2 | 2019 | 10085 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2013 | 2100 | 0.020 |
Why?
|
Case-Control Studies | 3 | 2013 | 21194 | 0.020 |
Why?
|
Adult Stem Cells | 1 | 2011 | 241 | 0.020 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2010 | 462 | 0.020 |
Why?
|
Pneumococcal Vaccines | 1 | 2013 | 429 | 0.020 |
Why?
|
Young Adult | 5 | 2014 | 55940 | 0.020 |
Why?
|
Cyclin D | 1 | 2008 | 66 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6562 | 0.020 |
Why?
|
Dilatation, Pathologic | 1 | 2010 | 517 | 0.020 |
Why?
|
Cholic Acid | 1 | 2008 | 34 | 0.020 |
Why?
|
Survival Analysis | 2 | 2012 | 10507 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2012 | 1374 | 0.020 |
Why?
|
Piperidines | 1 | 2016 | 1582 | 0.020 |
Why?
|
Virus Diseases | 1 | 2013 | 674 | 0.020 |
Why?
|
Cell Division | 2 | 2007 | 4752 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2011 | 1988 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2009 | 10525 | 0.020 |
Why?
|
Hyperplasia | 1 | 2010 | 1182 | 0.020 |
Why?
|
Transcription Factor AP-1 | 1 | 2008 | 332 | 0.020 |
Why?
|
Genetic Markers | 1 | 2013 | 2690 | 0.020 |
Why?
|
Cell Cycle | 1 | 2014 | 3014 | 0.020 |
Why?
|
Tacrolimus | 1 | 2009 | 717 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 7026 | 0.020 |
Why?
|
Cyclins | 1 | 2008 | 595 | 0.020 |
Why?
|
Gene Dosage | 1 | 2010 | 1271 | 0.020 |
Why?
|
Eosinophilia | 1 | 2010 | 517 | 0.020 |
Why?
|
Remission Induction | 1 | 2011 | 2399 | 0.020 |
Why?
|
Administration, Oral | 1 | 2013 | 3944 | 0.020 |
Why?
|
Students, Medical | 1 | 2018 | 1740 | 0.020 |
Why?
|
Chemoprevention | 1 | 2008 | 313 | 0.020 |
Why?
|
CpG Islands | 1 | 2010 | 1177 | 0.020 |
Why?
|
Carcinogens | 1 | 2007 | 393 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2015 | 2709 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 651 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2015 | 58184 | 0.020 |
Why?
|
Chromosomal Instability | 1 | 2005 | 165 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2010 | 2668 | 0.020 |
Why?
|
Base Sequence | 2 | 2008 | 13352 | 0.020 |
Why?
|
Point Mutation | 1 | 2009 | 1656 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2012 | 2427 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2013 | 2498 | 0.020 |
Why?
|
DNA Primers | 1 | 2008 | 3002 | 0.020 |
Why?
|
Bone Marrow | 1 | 2014 | 2938 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2008 | 895 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2009 | 1425 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2016 | 2176 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2013 | 3563 | 0.010 |
Why?
|
Medicare | 1 | 2020 | 5691 | 0.010 |
Why?
|
Receptors, Androgen | 1 | 2009 | 1060 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 2002 | 446 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2013 | 4422 | 0.010 |
Why?
|
Hematologic Neoplasms | 1 | 2013 | 1687 | 0.010 |
Why?
|
Leukemia | 1 | 2009 | 1496 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5197 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2007 | 1004 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2013 | 3507 | 0.010 |
Why?
|
beta Catenin | 1 | 2007 | 1053 | 0.010 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2009 | 1597 | 0.010 |
Why?
|
Physicians | 1 | 2018 | 4292 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2008 | 3693 | 0.010 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2010 | 1922 | 0.010 |
Why?
|
MAP Kinase Signaling System | 1 | 2007 | 1588 | 0.010 |
Why?
|
Macrophages | 1 | 2014 | 5784 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 4865 | 0.010 |
Why?
|
Pilot Projects | 1 | 2011 | 7994 | 0.010 |
Why?
|
Biopsy | 1 | 2010 | 6766 | 0.010 |
Why?
|
Random Allocation | 1 | 2002 | 2455 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 13274 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2002 | 1682 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2007 | 1805 | 0.010 |
Why?
|
Chronic Disease | 1 | 2011 | 8992 | 0.010 |
Why?
|
Internship and Residency | 1 | 2016 | 5556 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2009 | 3866 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2008 | 3025 | 0.010 |
Why?
|
Reference Values | 1 | 2002 | 5041 | 0.010 |
Why?
|
DNA Repair | 1 | 2005 | 2028 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 15485 | 0.010 |
Why?
|
Blood Glucose | 1 | 2009 | 6255 | 0.010 |
Why?
|
Insulin | 1 | 2009 | 6648 | 0.010 |
Why?
|
Incidence | 1 | 2011 | 20320 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 23020 | 0.010 |
Why?
|
United States | 1 | 2020 | 67165 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2003 | 8593 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2008 | 20170 | 0.010 |
Why?
|
Disease Progression | 1 | 2008 | 13298 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2002 | 18748 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2017 | 71483 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 11253 | 0.010 |
Why?
|
Time Factors | 1 | 2009 | 41038 | 0.000 |
Why?
|
Adolescent | 1 | 2009 | 84718 | 0.000 |
Why?
|